CSL clears hurdles to settle $16.4b Vifor deal

MELBOURNE: CSL will complete its biggest purchase to date after receiving regulatory clearance ... read more

Takeover bid for ResApp final says determined Pfizer

MELBOURNE: Pfizer has told ASX-listed ResApp it will not increase its 20.8c per ... read more

Opthea locks in $239m for eye disease drug trials

MELBOURNE: Opthea has landed one of the biggest biotech raisings of the year, ... read more

ICG now set to hire Lazard for Healius pursuit

MELBOURNE: Intermediate Capital is understood to have hired advisory firm Lazard in its ... read more